Kenilworth, N.J. - Clarinex, a new systemic drug for treatmentof urticaria (hives), has been approved by the Food and Drug Administration(FDA), according to Schering-Plough, the drug's manufacturer.
Recent Povorcitinib 2b Study Shows Improved Repigmentation
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
POLL: What Topics Did You Most Enjoy at AAD 2023?
Lanolin Named Allergen of the Year
2 Clarke Drive Cranbury, NJ 08512